Malarial Drug Delivery Systems: Advances in Treatment of Infectious Diseases | Agenda Bookshop Skip to content
Age Group_Uncategorized
Age Group_Uncategorized
automatic-update
B01=Ranjita Shegokar
B01=Yashwant Pathak
Category1=Non-Fiction
Category=MMFM
Category=MMG
Category=MMRT
Category=PSB
Category=TBN
Category=TCB
COP=Switzerland
Delivery_Pre-order
Language_English
PA=Not yet available
Price_€100 and above
PS=Active
softlaunch

Malarial Drug Delivery Systems: Advances in Treatment of Infectious Diseases

★★★★★
★★★★★

English

This book targets new advances in areas of treatment and drug delivery sciences for Malaria.  This is the only published book which compiles the complete road map of malarial drug delivery systems along with an overview on the pathology, current state of malaria across the globe, new clinical trials, emerging drugs and evolving novel drug delivery platforms.   A wide variety of novel micro-and nano-formulations using promising technologies are being explored to deliver the malarial drug via different administration routes. This book addresses the gap between new approaches and old treatment modalities and how the former is superior in pharmacological performance when tested in in-vitro and in-vivo. Audience from wide range group like from researchers to regulatory bodies can benefit from the compiled information to find out patient needs and addresses a much-needed update to the existing malaria drug delivery research. See more
€133.10
€152.99
Save 13%
Age Group_Uncategorizedautomatic-updateB01=Ranjita ShegokarB01=Yashwant PathakCategory1=Non-FictionCategory=MMFMCategory=MMGCategory=MMRTCategory=PSBCategory=TBNCategory=TCBCOP=SwitzerlandDelivery_Pre-orderLanguage_EnglishPA=Not yet availablePrice_€100 and abovePS=Activesoftlaunch

Will deliver when available. Publication date 28 Mar 2024

Product Details
  • Dimensions: 155 x 235mm
  • Publication Date: 07 Mar 2024
  • Publisher: Springer International Publishing AG
  • Publication City/Country: Switzerland
  • Language: English
  • ISBN13: 9783031165061

About

Dr. Ranjita Shegokar holds a Ph.D. degree in Pharmaceutical Technology from the SNDT University India and has been a postdoctoral researcher in the Department of Pharmaceutics Biopharmaceutics and NutriCosmetics at the Free University of Berlin Germany. Since last several years she is working with various multinational pharmaceutical companies at technical/R&D leadership roles. Currently she serves as a Chief Scientific Officer CapnoPharm GmbH Germany. She has authored several research articles book chapters and presented her research in many national/international conferences. She has filed multiple patent applications in the area of drug delivery and active targeting. Besides that she edited many trending books on nanoparticles and their aspects. For her research she received many prestigious national and international awards among them the recent one is German Innovation Award 2022. Her areas of interest include polymeric nanoparticles nanocrystals lipid nanoparticles (SLNs/NLCs) nanoemulsions for targeting various diseases and the role of excipients in developing the same.Dr. Yashwant Pathak completed his Ph.D. in Pharmaceutical Technology from India and EMBA and MS Conflict Management from Sullivan University USA. He is Associate Dean for Faculty Affairs College of Pharmacy University of South Florida. Tampa Florida. With extensive experience in academia and industry he has over 150 research publications abstracts chapters and reviews 7 books in Nanotechnology and drug delivery systems 6 in Nutraceuticals and several books in cultural studies. His areas of research include drug delivery systems nanotechnology applications for pharmaceutical and Nutraceuticals. He has traveled extensively over 80 countries to network scientific experts and is actively involved with many Pharmacy colleges in different countries.

Customer Reviews

Be the first to write a review
0%
(0)
0%
(0)
0%
(0)
0%
(0)
0%
(0)
We use cookies to ensure that we give you the best experience on our website. If you continue we'll assume that you are understand this. Learn more
Accept